Short-course Regimens for the Treatment of Pulmonary Tuberculosis

NCT05766267 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

288

Enrollment

FED

Sponsor class

Conditions

Tuberculosis, Pulmonary
Tuberculosis Infection

Interventions

DRUG: Rifabutin
DRUG: Delamanid
DRUG: Bedaquiline
DRUG: Moxifloxacin
DRUG: Pyrazinamide
DRUG: Isoniazid
DRUG: Rifampin
DRUG: Ethambutol

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]